Glass half full: Improving outcomes in patients with circulating tumor DNA molecular residual disease Contributor, Nature Cancer Behind the paper Glass half full: Improving outcomes in patients with circulating tumor DNA molecular residual disease Everett J Moding Jan 20, 2020
